Novel compounds and drugs and recent patents in treating multidrug-resistant and extensively drug-resistant tuberculosis
A number of recent studies revealed that successful treatment of the patients with MDR/XDR- TB was not achieved due to high resistant rates to many second-line drugs such as kanamycin and prothionamide including poor adherence of the lengthy treatment. Many new drugs and compounds such as benzothiaz...
Saved in:
Main Authors: | Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863919123&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Novel compounds and drugs and recent patents in treating multidrug-resistant and extensively drug-resistant tuberculosis
by: Cheepsattayakorn A., et al.
Published: (2014) -
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Risara Jaksuwan, et al.
Published: (2018) -
In vitro activity and MIC of sitafloxacin against multidrug- resistant and extensively drug-resistant mycobacterium tuberculosis isolated in Thailand
by: Manoon Leechawengwongs, et al.
Published: (2019) -
Treatment of multidrug-resistant tuberculosis in Thailand
by: Khun Nanta Maranetra
Published: (2018) -
An updated literature review concerning the treatment cost of multidrug-resistant tuberculosis
by: Quang Vinh Tran, et al.
Published: (2019)